1. Brief Introduction of Institut Pasteur of Shanghai
Institut Pasteur of Shanghai – Chinese Academy of Sciences (IPS-CAS) is a scientific research institute founded in 2004 by the Chinese Academy of Sciences, the Shanghai Municipal Government, and the Institut Pasteur in Paris. It is a member of the Institut Pasteur International Network (IPIN), the WHO and other NGOs. IPS-CAS creates synergies between the Institut Pasteur and CAS networks, leveraging all the assets of Shanghai as one of Asia’s leading business and technology hubs. Our scientists are engaged in a broad range of infectious disease research programs ranging from viral hepatitis, HIV, respiratory infections to virus-induced cancers.
IPS-CAS is in an ideal strategic position to conduct research and development in life sciences in China. Together with its academic and industry partners, IPS’s goal is to develop product candidates in the field of diagnostics, vaccines and therapeutics.
2. Joint Post-doctoral Training Program
IPS-CAS and Guangzhou Women and Children's Medical Center (GWCMC) –Joint Research Center in Infection and Immunity have launched a postdoctoral training program. Now this program opens to young scientists from all over the world.
This program focuses on translational medicine, and any candidates who have experience or expertise in infection and immunology, or its related fields, are encouraged to apply for. Our program is featured by dual-mentor system from both the Institute and the Medical Center, post-doctor research fund (up to 0.5 million RMB), and multiple training sites with an emphasis on translational studies from basic bench work to clinical application. Candidates should have a recent PhD or its related degree, self-motivated, fluent in either Chinese or English, with a tracking record of successful graduate training. People from any minority are also encouraged to apply for. The salary and benefit will be highly competitive, dependent on the qualification. However, once successfully enrolled, and minimal annual income should be no less than 220.000 RMB (before tax), in addition to attractive incentive awards.
Mentor information:
| No. | Name | Unit Name | Research Focus |
| 1 | Wang Haikun | The regulationofImmune celldifferentiation Unit | Follicular helper T cells and clinical applications |
| 2 | Leng Qibin | Immune regulation Unit | T cell immunity in cancers and autoimmune diseases and its applications in immunotherapy |
| 3 | Zhou Dongming | Anti-infection immunity and vaccine research Unit | Adenoviral vector-based vaccine development and cancer gene therapy |
| 4 | Chen Changbin | Pathogenic fungal infection and host immunity Unit | Molecular mechanisms of pathogenic fungal infection and host anti-fungal immune responses specially in gastrointestinal tract, lung and genital tract |
| 5 | Meng Guangxun | Innate Immunity Unit | Mechanism for the regulation of inflammasome and its function in the pulmonary mucosa |
| 6 | Tang Hong | Inflammation and Immunopathology Unit | Immunopathogenic mechanisms for viral and bacterial infections |
| 7 | Zhang Yan | Hematopoietic stem cell and transgenic animal model Unit | The regulatory mechanisms of hematopoietic immune system developmentin the context of infections |
| 8 | Zhang Xiaoming | Unit of Innate Defense and Immune Modulation | Systems immunology in human health and diseases (Sepsis, Liver disease, etc.) |
| 9 | Jiang Lubin | Unit of human parasite molecular and cell biology | Epigenetic regulation in pathogen infection |
| 10 | Xiao Hui | Immune Signaling and Regulation Unit | Innate immune mechanisms in skin infection and inflammation |
| 11 | Wang Lanfeng | Structual biology of Pathogenic mechanism Unit | Elucidation of the molecular mechanism of pathogenesis using multidisciplinary tools including Structure Biology, Biochemistry, Cell biology, and et al. Then developing the more effective ways to prevent or cure the related diseases |
| 12 | Su Xiao | Unit of Respiratory Infection and Hstopathology | Molecular mechanisms of the pathogenesis of acute lung injury; nerve-mediated regulatory mechanisms in influenza virus and EV71 virus infections |
| 13 | Huang Zhong | Vaccinology and antiviral strategies Unit | Norovirus infection and pathogenesis |
| 14 | Liang Xiaozhen | virus-associated lymphomagenesis Unit | Pathogenesis of EBV infection and associated diseases |
| 15 | Zhang Chiyu | Pathogen Diagnostic Center | Finding and identification of known and/or unknown pathogens associated with infection among children and women |
| 16 | Hao Pei | Bioinformatics Platform | Integrated Omics Study on Pathogens Microbes and Infection |
| 17 | Dimitri Lavillette | Arbovirus interspecies transmission and therapeutics Unit | Tropism and Mechanism of maternal-fetus transmission of mosquito-borne virus |
| 18 | Qian Zhikang | Herpes virus and molecular virology research Unit | Cytomegalovirus regulating stem cell proliferation, differentiation and molecular mechanisms of programmed cell death |
| 19 | Wang Jianhua | Viral immunology Unit | Host modulation on retrovirus replication and the antiviral strategies |
| 20 | Zhong Jin | Viral hepatitis Unit | Molecular virology of hepatitis C virus and Zika virus |
| 21 | Long Gang | Virus assembly and host dependency Unit | Molecular Biology of Zika Virus |
For more information about IPS-CAS, please visit the website:
http://english.shanghaipasteur.cas.cn
3. Job Application
a. Application materials:
-Application Form
-CV in English
-Two recommendation letters or contact information including phone and e-mail of two references
-Additional materials (including: copy of ID, copy of academic degree certificate, a copy of award certificate, issued patents or published papers etc. into a single PDF file)
Please send e-mail to: hrips@ips.ac.cn and write "Joint Postdoctoral Training Program + name of selected mentor" in the message object.
b. Contact:
IPS-CAS Human Ressources Department : Ms.Liang +86-21-54923012
c. Application deadline:
31th December 2016
